| |
| Issue |
Title |
| |
| No 3 (2025) |
Catestatin as a potential diagnostic marker of metabolic syndrome |
Abstract
PDF (Rus)
|
|
D. K. Kuznetsova, I. V. Gubareva, A. V. Pashentseva |
| |
| No 3 (2025) |
Cathestatin and metabolic syndrome in patients with hypertension |
Abstract
PDF (Rus)
|
|
L. Yu. Shvan, I. V. Gubareva, S. A. Tokarev, E. Yu. Gubareva |
| |
| No 3 (2025) |
Metabolic syndrome, cognitive impairments, the role of nutrition |
Abstract
PDF (Rus)
|
|
S. V. Bulgakova, D. P. Kurmaev, E. V. Treneva, O. V. Kosareva, P. Ya. Merzlova, L. A. Sharonova, Yu. A. Dolgikh, N. A. Pervyshin, P. I. Romanchuk, A. S. Bulgakov |
| |
| No 3 (2025) |
Anorexia nervosa as a cause of endocrine disorders |
Abstract
PDF (Rus)
|
|
P. Ya. Merzlova, S. V. Bulgakova, Yu. A. Dolgikh, L. A. Sharonova, O. V. Kosareva |
| |
| No 3 (2025) |
The relationship between obesity, metabolic syndrome and thyroid pathology |
Abstract
PDF (Rus)
|
|
O. V. Kosareva, S. V. Bulgakova, Yu. A. Dolgikh, L. A. Sharonova, P. Ya. Merzlova, E. V. Treneva, D. P. Kurmaev |
| |
| No 3 (2025) |
Children’s origins of chronic diseases in adults: focus on obesity and metabolic syndrome (literature review) |
Abstract
PDF (Rus)
|
|
N. B. Migacheva, O. V. Skvortsova |
| |
| No 3 (2025) |
Unexpected links between metabolic syndrome, cognitive deficit, astrocyte dysfunction and brain glymphatic activity: general patterns and relationships |
Abstract
PDF (Rus)
|
|
I. V. Shirolapov, A. V. Zakharov, O. N. Pavlova, O. V. Borisova, S. V. Bulgakova, D. P. Kurmaev |
| |
| No 3 (2025) |
Metabolic dysfunctionassociated steatotic liver disease in the setting of metabolic syndrome |
Abstract
PDF (Rus)
|
|
O. V. Tsygankova, V. V. Veretyuk, O. V. Timoshchenko |
| |
| No 3 (2025) |
Erythrocyte and serum membrane fatty acids as biomarkers for differentiation of initial and advanced fibrosis in patients with fatty liver disease of alcoholic and mixed genesis |
Abstract
PDF (Rus)
|
|
M. V. Kruchinina, M. F. Osipenko, R. A. Bukarev, Yu. V. Makarova, A. A. Gromov |
| |
| No 3 (2025) |
The effect of obesity on the rate of progression of chronic kidney disease in elderly patients with type 2 diabetes |
Abstract
PDF (Rus)
|
|
N. A. Pervyshin, S. V. Bulgakova, M. V. Komarova, A. A. Chertischeva |
| |
| No 3 (2025) |
Metabolic syndrome and chronic kidney disease: the relationship of the leading components of metabolic syndrome with kidney damage and the features of their drug correction |
Abstract
PDF (Rus)
|
|
L. A. Sharonova, S. V. Bulgakova, O. V. Kosareva, Yu. A. Dolgikh, P. Ya. Merzlova, E. V. Treneva, D. P. Kurmaev, A. A. Sharonova |
| |
| No 3 (2025) |
Chronic kidney disease leads to skeletal muscle wasting |
Abstract
PDF (Rus)
|
|
S. V. Bulgakova, D. P. Kurmaev, E. V. Treneva |
| |
| No 3 (2025) |
Chronic liver diseases as a cause of sarcopenia development |
Abstract
PDF (Rus)
|
|
D. P. Kurmaev, S. V. Bulgakova, E. V. Treneva, O. V. Kosareva, P. Ya. Merzlova, L. A. Sharonova, Yu. A. Dolgikh |
| |
| No 3 (2025) |
Sarcopenic obesity and metabolic disorders in ageing |
Abstract
PDF (Rus)
|
|
D. P. Kurmaev, S. V. Bulgakova, E. V. Treneva, O. V. Kosareva, L. A. Sharonova, Yu. A. Dolgikh, P. Ya. Merzlova |
| |
| 1 - 14 of 14 Items |
|
